Generation and characterization of an anti-GP73 monoclonal antibody for immunoblotting and sandwich ELISA

Journal of Biomedical Research

Volumn 26, Issue 6, 2012, Pages 467-473

  Zhang, Aixia ^a   Cao, Brian ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b VAN ANDEL RESEARCH INSTITUTE   (United States)

Author keywords

GP73; Hepatocellular carcinoma; Monoclonal antibody; Sandwich ELISA; Western blotting

Indexed keywords

GOLGI PROTEIN 73 MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYBRIDOMA; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 84870911833     PISSN: 16748301     EISSN: None     Source Type: Journal    
DOI: 10.7555/JBR.26.20120057     Document Type: Article

References (19)

1. Kladney RD, Bulla GA, Guo L, Mason AL, Tollefson AE, Simon DJ, et al. GP73, a novel Golgi-localized protein upregulated by viral infection. Gene 2000, 249:53-65.
2. Kladney RD, Cui X, Bulla GA, Brunt EM, Fimmel CJ Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease. Hepatology 2002, 35:1431-1440.
3. Iftikhar R, Kladney RD, Havlioglu N, Schmitt-Gräff A, Gusmirovic I, Solomon H, et al. Disease- and cell-specific expression of GP73 in human liver disease. Am J Gastroenterol 2004, 99:1087-1095.
4. Block TM, Comunale MA, Lowman M, Steel LF, Romano PR, Fimmel C, et al. Use of targeted glycoproteins to identify serum glycoproteins that correlated with liver cancer in woodchucks and humans. Proc Natl Acad Sci U S A 2005, 102:779-784.
5. Hu JS, Wu DW, Liang S, Miao XY GP73, a resident Golgi glycoprotein, is sensibility and specificity for hepatocellular carcinoma of diagnosis in a hepatitis B-endemic Asian population. Med Oncol 2010, 27:339-345.
6. Puri S, Bachert C, Fimmel CJ, Linstedt AD Cycling of early Golgi proteins via the cell surface and endosomes upon lumenal pH disruption. Traffic 2002, 3:641-653.
7. Bachert C, Fimmel C, Linstedt AD Endosomal trafficking and proprotein convertase cleavage of cis Golgi protein GP73 produces marker for hepatocellular carcinoma. Traffic 2007, 8:1415-1423.
8. Marrero JA, Romano PR, Nikolaeva O, Steel L, Mehta A, Fimmel CJ, et al. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma. J Hepatol 2005, 43:1007-1012.
9. Riener MO, Stenner F, Liewen H, Soll C, Breitenstein S, Pestalozzi BC, et al. Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas. Hepatology 2009, 49:1602-1609.
10. Gu Y, Chen W, Zhao Y, Chen L, Peng T Quantitative analysis of elevated serum Golgi protein-73 expression in patients with liver diseases. Ann Clin Biochem 2009, 46:38-43.
11. Fimmel CJ, Wright L Golgi protein 73 as a biomarker of hepatocellular cancer: development of a quantitative serum assay and expression studies in hepatic and extra-hepatic malignancies. Hepatology 2009, 49:1421-1423.
12. Hadji-Ghasemi F, Gharagozlou S, Ghods R, Roohi A, Khoshnoodi J, Shokri F Generation and characterization of a mouse monoclonal antibody with specifi{ligature}city similar to staphylococcalproteinA (SPA). Hybrid Hybridomics 2003, 22:33-39.
13. Coligan JE Preparation and application of polyclonal and monoclonal sequence-specific anti-phosphoamino acid antibodies. Curr Protoc Protein Sci 2004, 13.16.11-113.16.22. John Wiley & Sons Inc, New Jersey. T. Sun, R.B. Arlinghavs (Eds.).
14. Kristiansen G, Fritzsche FR, Wassermann K, Jäger C, Tölls A, Lein M, et al. GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics. Br J Cancer 2008, 99:939-948.
15. Wei S, Dunn TA, Isaacs WB, De Marzo AM, Luo J GOLPH2 and MYO6: putative prostate cancer markers localized to the Golgi apparatus. Prostate 2008, 68:1387-1395.
16. Zhou Y, Yin X, Ying J, Zhang B Golgi protein 73 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: a diagnostic meta-analysis. BMC Cancer 2012, 12:17.
17. Mao Y, Yang H, Xu H, Lu X, Sang X, Du S, et al. Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma. Gut 2010, 59:1687-1693.
18. Anderson NL, Anderson NG The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2002, 1:845-867.
19. Varambally S, Laxman B, Mehra R, Cao Q, Dhanasekaran SM, Tomlins SA, et al. Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancer. Neoplasia 2008, 10:1285-1294.